Literature DB >> 11352787

Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus.

J S Navratil1, J M Ahearn.   

Abstract

Cell death by apoptosis is an integral part of many biologic processes, including embryonic development, T- and B-cell selection, the elimination of potentially autoreactive lymphocytes in the periphery, and maintenance of lymphocyte homeostasis through activation-induced cell death. There is also increasing evidence that apoptosis may maintain immune tolerance and that it may be the process that generates the self antigens responsible for the initial development of autoimmunity. This review discusses some of the biochemical steps involved in the apoptotic process, how potentially immunogenic self antigens are generated during apoptosis, and the mechanisms by which the products of apoptosis are cleared and processed to avoid breaking immune tolerance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352787     DOI: 10.1007/s11926-001-0018-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  58 in total

1.  FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

Authors:  A M Chinnaiyan; K O'Rourke; M Tewari; V M Dixit
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

2.  Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes.

Authors:  M E Miranda; C E Tseng; W Rashbaum; R L Ochs; C A Casiano; F Di Donato; E K Chan; J P Buyon
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

Review 3.  Complement deficiency and autoimmunity.

Authors:  M J Walport; K A Davies; B J Morley; M Botto
Journal:  Ann N Y Acad Sci       Date:  1997-04-05       Impact factor: 5.691

4.  Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies.

Authors:  A A Manfredi; P Rovere; G Galati; S Heltai; E Bozzolo; L Soldini; J Davoust; G Balestrieri; A Tincani; M G Sabbadini
Journal:  Arthritis Rheum       Date:  1998-02

5.  Caspase-9 can be activated without proteolytic processing.

Authors:  H R Stennicke; Q L Deveraux; E W Humke; J C Reed; V M Dixit; G S Salvesen
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

6.  TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation.

Authors:  L Zhuang; B Wang; G A Shinder; G M Shivji; T W Mak; D N Sauder
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

7.  The 72-kDa component of signal recognition particle is cleaved during apoptosis.

Authors:  P J Utz; M Hottelet; T M Le; S J Kim; M E Geiger; W J van Venrooij; P Anderson
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

8.  Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis.

Authors:  R Caricchio; E A Reap; P L Cohen
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

9.  Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus.

Authors:  P J Utz; M Hottelet; P H Schur; P Anderson
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

10.  Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis.

Authors:  C A Casiano; S J Martin; D R Green; E M Tan
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  15 in total

1.  Defective waste disposal: does it induce autoantibodies in SLE?

Authors:  Peter J Charles
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  In vitro reconstitution of the interactions in the PIDDosome.

Authors:  Tae-ho Jang; Chao Zheng; Hao Wu; Ju-Hong Jeon; Hyun Ho Park
Journal:  Apoptosis       Date:  2010-12       Impact factor: 4.677

3.  Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus.

Authors:  Ou Jin; Ling-yun Sun; Kang-xin Zhou; Xin-su Zhang; Xue-bing Feng; Mo-yin Mok; Chak-sing Lau
Journal:  Clin Rheumatol       Date:  2004-07-28       Impact factor: 2.980

4.  Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus.

Authors:  Ravichandran Panchanathan; Xin Duan; Hui Shen; Vijay A K Rathinam; Loren D Erickson; Katherine A Fitzgerald; Divaker Choubey
Journal:  J Immunol       Date:  2010-11-05       Impact factor: 5.422

5.  Nuclear-targeting autoantibodies induced nuclear PARP cleavage accompanied by more pronounced decrease of peripheral white blood cells than Ro/SSA and La/SSB antigen-targeting autoantibodies.

Authors:  Ingrid Böhm
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

6.  [The apoptosis marker enzyme poly-(ADP-ribose) polymerase (PARP) in systemic lupus erythematosus].

Authors:  I Böhm
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

7.  Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients.

Authors:  James C Oates; Libby W Farrelly; Ann F Hofbauer; Wei Wang; Gary S Gilkeson
Journal:  Arthritis Rheum       Date:  2007-11

8.  A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.

Authors:  Hava Ben-David; Amir Sharabi; Reshmi Parameswaran; Heidy Zinger; Edna Mozes
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

9.  Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study.

Authors:  Murray B Urowitz; David A Isenberg; Daniel J Wallace
Journal:  Lupus Sci Med       Date:  2015-08-11

10.  The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus.

Authors:  Yu-Jih Su; Tien-Tsai Cheng; Chung-Jen Chen; Wen-Chan Chiu; Chung-Yuan Hsu; Wen-Neng Chang; Nai-Wen Tsai; Chia-Te Kung; Hung-Chen Wang; Wei-Che Lin; Chih-Cheng Huang; Ya-Ting Chang; Chih-Min Su; Yi-Fang Chiang; Ben-Chung Cheng; Yu-Jun Lin; Cheng-Hsien Lu
Journal:  J Transl Med       Date:  2013-10-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.